Lead Plaintiffs Seek Class Certification In Securities Suit Against Drug Maker

(July 14, 2017, 1:31 PM EDT) -- BOSTON — A federal judge should grant a motion for class certification filed by lead plaintiffs in a securities class action lawsuit against a biopharmaceutical company and certain of its executive officers because the lead plaintiffs have satisfied all statutory requirements for certification, the lead plaintiffs argue in a motion for class certification filed June 29 in Massachusetts federal court (In re AVEO Pharmaceuticals Inc. Securities Litigation, No. 13-11157, D. Mass.).

(Motion for class certification available.  Document #57-170717-503B.)

Lead plaintiffs Robert Levine and William Windham filed...
To view the full article, register now.